Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-16

Clinical Trial Update: Fluticasone and Salmeterol in Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating fluticasone and salmeterol for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • fluticasone and salmeterol

Snippet

Sponsor: University of Dundee | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED